FIB-4 Indeterminate: What Comes Next in Practice?
Operational discussion of how clinics handle indeterminate FIB-4 results and when non-invasive staging pathways are considered.
Read article →Blog
Data-led articles and buyer guides for Australian clinicians evaluating liver elastography.
GP Liver Screening Guide: Structuring a Practical Primary-Care Pathway
How GP clinics can structure consistent liver risk workflows with clear triage, follow-up, and referral logic.
Read article →Liver Scan in Obese Patients: Practical Considerations for Clinics
Operational guide to non-invasive liver assessment in higher-BMI cohorts, including workflow and acquisition considerations.
Read article →FibroScan Alternatives in Australia: A Buyer's Guide to Liver Elastography
What Australian buyers evaluate when comparing transient elastography systems: guidance, workflow, obese-patient performance, probes, and total cost of ownership.
Read article →The MAFLD Screening Gap in Australia (and What Clinics Can Do Next)
Why metabolic liver disease is under-detected in Australian primary care, how risk stratification is evolving, and where guided elastography fits in the pathway.
Read article →